期刊文献+

中药柴贝止痫汤对难治性癫痫大鼠多药耐药基因MDR1表达的研究 被引量:16

Effects of Chaibei Zhixian Decoction on the expressions of MDR1 in intractable epileptic rats
下载PDF
导出
摘要 [目的]通过比较不同药物干预对多药耐药基因1(MDR1)的影响,观察难治性癫痫大鼠脑内MDR1mRNA的表达和分布,探讨难治性癫痫多药耐药可能的分子病理机制,及中药复方柴贝止痫汤对其表达的影响。[方法]以不同药物干预下,观察癫痫发作的平均持续时间、癫痫发作级别,以判定、分析药物的疗效。采用荧光实时定量聚合敏链反应(PCR)的方法,分析、比较多药耐药基因MDR1在各组大鼠海马和皮质部位的表达和分布。[结果]与正常组大鼠比较,各致痫组MDR1mRNA表达含量均有明显增高,具有统计学意义(P<0.05)。[结论]癫痫的反复发作可以诱导慢性难治性癫痫大鼠海马和皮质MDR1mRNA的表达,中药复方柴贝止痫汤具有一定抑制MDR1药物转运体功能。 [Objective] To investigate the effects of Chaibei Zhixian decoction, a Chinese herbal compound, on the expression and distribution of multiple drug resistance gene 1 (MDR1) mRNA in intractable epileptic rats, to explore the possible molecular pathogenesis mechanism of the intractable epilepsy. [Methods] The average duration of seizures and the Racine's stage of epileptic seizure under different drug's intervention were observed to judge and analyze their effects. Real-time PCR was used to compare the expression and distribution of MDR1 in the hippocampus and cerebral cortex of the rats. [Results] Compared with the normal group, the expression of MDR1 mRNA was significantly elevated in all epileptic groups. ( P〈0.05). [Conclusion] Spontaneous recurrent seizure can induce the expression of MDR1 in the hippocampus and cerebral cortex in chronic intractable epileptic rats. The Chinese herbal compound Chaibei Zhixian Tang had some efficacy in inhibiting MDR1 drug transporters.
出处 《天津中医药》 CAS 2009年第6期472-475,共4页 Tianjin Journal of Traditional Chinese Medicine
基金 高等学校博士学科点专项科研基金(20060026002)
关键词 难治性癫痫 多药耐药基因1 柴贝止痫汤 卡马西平 intractable epilepsy multiple drug resistance gene 1 Chaibei Zhixian Tang carbamazepine
  • 相关文献

参考文献4

二级参考文献23

  • 1张立阳,赵玉沛,廖泉,郭俊超,刘子文,张太平.维拉帕米逆转胰腺癌化疗耐药的研究[J].中华肝胆外科杂志,2004,10(4):263-266. 被引量:9
  • 2张洪涛,王和平,陈坚,雷霆,薛德麟.维拉帕米对脑膜瘤生长影响的实验研究(英文)[J].中国现代医学杂志,2005,15(6):811-814. 被引量:3
  • 3Hirofumi S,Gakuji O,Shinji A,et al. Immunohistochemical localization of P-Glycoprotein and expression of the multidrug resistance-1gene in human pancreatic cancer: relevance to indication of better prognosis . Jpn J Cancer Res, 1996,87:641-649.
  • 4Gebaccer T, Ridwelski K, Fahlbe J. Locoregional and systemic therapy of advanced pancreatic carcinoma. Langenbecks Arch Chir,1988,115:1344-1347.
  • 5Ludescher C, Thaler J, Drach D, et al. Detection of P-glycoprotein in human tumor samples using rhodamine 123. Br J Haematol, 1992,82:161-168.
  • 6Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth and cell kill. J Immun Method, 1989,119-203.
  • 7Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross resistance, radioautographic and cytogenetic studies. Cancer Res, 1970,30:1174-1184.
  • 8Ozols RF, Cunnion RE, Klecher RW, et al. Verapamil and adriamycin in the treatment of drug-resistance ovarian cancer patients. J Clin Oncol, 1987,5:641-647.
  • 9Thurlimann B, Kroger M, Greiner J, et al. Decverapamil to overcome epirubicin resistance in advanced breast cancer. J Cancer Res Clin Oncol,1995,121:R3-6.
  • 10Nazlio O,Tansug T,Bozdag AD,et al. Locoregional chemotherapy in pancratic cancer. Hepatogastroenterology, 1999, 46:479-482.

共引文献10

同被引文献199

引证文献16

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部